Breadcrumb Home Research 31st Annual CSIBD Workshop and 2nd Broad Immunology Program Symposium Center for the Study of Inflammatory Bowel Disease Symposium 31ST Annual CSIBD WorkshopSecond Immunology Program Symposium 31st Annual Center for the Study of Inflammatory Bowel Disease Workshop Thursday – November 18th, 2021 The Symposium is open to the research community at no charge. 8:50 – 9:00 CSIBD Overview Ramnik J. Xavier, M.D., Director Session I: Innate sensing at the host-microbe interface Moderators: Gail Hecht / Cheri Sirois 9:00 - 9:30 Mechanisms involved in the restriction of SARS-CoV2 Infection. Kate Fitzgerald, Ph.D. 9:30 - 10:00 Pyroptosis in antibacterial & antitumor immunity Feng Shao, Ph.D. 10:00 - 10:30 Trapped in droplets: A new mode of sensing danger Hao Wu, Ph.D. 10:30 - 11:00 Initiation and Regulation of Innate Immunity Jonathan Kagan, Ph.D. 11:00 - 12:00 Keynote I Innate immune receptors: their links to adaptive immunity and the microbiome Jenny Ting, Ph.D. 12:00-1:00 Break Session II: Microbe engineering and microbial therapies Moderators: Curtis Huttenhower / Hera Vlamakis 1:00 - 1:30 Metagenomic modelling of fecal microbiota transplantation Nicola Segata, Ph.D. 1:30 - 2:00 Microbiota and cancer - an ecological journey Ben Boursi, M.D. 2:00 - 2:30 Characterization of narrow-spectrum antibiotics from patient isolates of Ruminococcus gnavus Matthew Henke, Ph.D. 2:30 - 3:00 Engineered bacteria for the site specific delivery of therapeutics to the gut Cammie Lesser, M.D., Ph.D. 3:00 - 3:30 Engineering and Rewilding the Gut Microbiome Justin Sonnenburg, Ph.D. 3:30 - 4:00 Predicting and Combating Biotic and Abiotic Disruptions to Diverse Microbiomes Gautam Dantas, Ph.D. 4:00 - 5:00 Roundtable: The Path to Microbiome-based Therapies (co-sponsored by CMIT) Session III: Inflammation and myeloid cell biology Moderators: Charles Elson / Jacques Deguine 9:00 - 9:30 Leveraging polygenic enrichments of gene features to predict genes underlying complex traits and diseases Hilary Finucane, Ph.D. 9:30 - 10:00 Molecular mechanism for self vs. non-self RNA discrimination Sun Hur, Ph.D. 10:00 - 10:30 Large-scale sequencing and multi-ancestry genetic analyses identify novel genes and variants associated with IBD Hailiang Huang, Ph.D. 10:30 - 11:00 Myeloid biology in dysregulated microenvironments and therapeutic opportunities Rosandra Kaplan, M.D. 11:00 - 11:30 Nutrient adaptation in the intestine Ruslan Medzhitov, Ph.D. 11:30 - 12:00 Immune-metabolic mechanisms of cognitive decline in aging Katrin Andreasson, M.D. 12:00 - 1:00 Break 1:00 - 2:00 Keynote II Commensal derived metabolites promote pro-inflammatory T cell differentiation and IBD pathogenesis Richard Flavell, Ph.D., FRS Session IV: Metabolism and Immunity Moderators: Thad Stappenbeck / Andrew Luster 2:00 - 2:30 NeuroImmunometabolism Ana Domingos, Ph.D. 2:30 - 3:00 Immunometabolism meets Immunothrombosis Luke O’Neill, Ph.D. 3:00 - 3:30 Diet, lipids and anti-tumor immunity Lydia Lynch, Ph.D. 3:30 - 4:00 Integrating metabolism with systems immunology in immunity and disease Hongbo Chi, Ph.D. 4:00 - 4:30 Tracey Simon, M.D. Immunology Program Events 31st CSIDB Workshop Second Broad Immunology Program Symposium Latest news News 11.03.2025 Biology of Adversity Project launches at Broad Institute News 10.31.2025 Carl June, Bruce Levine, Isabelle Rivière, and Michel Sadelain receive the 2025 Merkin Prize at the Broad Institute for chimeric antigen receptor (CAR) T-cell therapy News 10.31.2025 Genetic variant increases risk of heart muscle disease common in individuals of African ancestry News 10.16.2025 Broad-Bayer collaboration leads to drug candidate for a hard-to-treat type of lung cancer All news
News 10.31.2025 Carl June, Bruce Levine, Isabelle Rivière, and Michel Sadelain receive the 2025 Merkin Prize at the Broad Institute for chimeric antigen receptor (CAR) T-cell therapy
News 10.31.2025 Genetic variant increases risk of heart muscle disease common in individuals of African ancestry
News 10.16.2025 Broad-Bayer collaboration leads to drug candidate for a hard-to-treat type of lung cancer